Cargando…

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up

BACKGROUND: Heterogeneity of prostate cancer (PCa) contributes to inaccurate cancer screening and diagnosis, unnecessary biopsies, and overtreatment. We intended to develop non-invasive urine tests for accurate PCa diagnosis to avoid unnecessary biopsies. METHODS: Using a machine learning program, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Heather, Guo, Jinan, Zhang, Xuhui, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan H. B., Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Kenner, Lukas, Feng, Xiaoyan, Zou, Chang, Xiao, Kefeng, Persson, Jenny L., Chen, Lingwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706045/ https://www.ncbi.nlm.nih.gov/pubmed/33256740 http://dx.doi.org/10.1186/s12916-020-01834-0

Ejemplares similares

A 23‐Gene Classifier urine test for prostate cancer prognosis
por: Guo, Jinan, et al.
Publicado: (2021)

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
por: Guo, Jinan, et al.
Publicado: (2021)

Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification
por: Guo, Jinan, et al.
Publicado: (2020)

Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
por: Sarwar, Martuza, et al.
Publicado: (2016)

The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
por: Larsson, Per, et al.
Publicado: (2019)

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013)

Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
por: Tinzl, Martina, et al.
Publicado: (2013)

Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
por: Tinzl, Martina, et al.
Publicado: (2018)

K-RAS Associated Gene-Mutation-Based Algorithm for Prediction of Treatment Response of Patients with Subtypes of Breast Cancer and Especially Triple-Negative Cancer
por: Johnson, Heather, et al.
Publicado: (2022)

Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients
por: Johnson, Heather, et al.
Publicado: (2022)

Cyclin A1 Modulates the Expression of Vascular Endothelial Growth Factor and Promotes Hormone-Dependent Growth and Angiogenesis of Breast Cancer
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2013)

Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions
por: Gobbo, Marina G., et al.
Publicado: (2015)

Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis
por: Wegiel, Barbara, et al.
Publicado: (2008)

Different expression levels of glycans on leukemic cells—a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid
por: El-Schich, Zahra, et al.
Publicado: (2016)

Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System
por: Albitar, Maher, et al.
Publicado: (2016)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer
por: Semenas, Julius, et al.
Publicado: (2020)

Identification of Novel RD1 Antigens and Their Combinations for Diagnosis of Sputum Smear−/Culture+ TB Patients
por: Liu, Zhiqiang, et al.
Publicado: (2016)

Generation of monoclonal antibodies against MGA and comparison of their application in breast cancer detection by immunohistochemistry
por: Duan, Cuimi, et al.
Publicado: (2015)

Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer
por: Ma, Xiaoshi, et al.
Publicado: (2023)

A multiple-antigen detection assay for tuberculosis diagnosis based on broadly reactive polyclonal antibodies
por: Dai, Zhenhua, et al.
Publicado: (2017)

Improved urine DNA methylation panel for early bladder cancer detection
por: Fang, Qixun, et al.
Publicado: (2022)

Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015)

Assessing the accuracy of [(18)F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
por: Ingvar, Jacob, et al.
Publicado: (2022)

Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase
por: Karlsson, Richard, et al.
Publicado: (2020)

An expanded biomarker panel for the detection of prostate cancer from urine DNA
por: Brikun, Igor, et al.
Publicado: (2019)

Urine creatine metabolite panel as a screening test in neurodevelopmental disorders
por: Bahl, Shalini, et al.
Publicado: (2020)

The Treatment of Retention of Urine, Etc.
por: Johnson, Jno. Thad.
Publicado: (1877)

2240. Implementation of a Clinical Decision Support Panel for Urine Culture Ordering
por: Yarrington, Michael E, et al.
Publicado: (2022)

A panel of urine-derived biomarkers to identify sepsis and distinguish it from systemic inflammatory response syndrome
por: Tang, Yao, et al.
Publicado: (2021)

The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
por: Sarwar, Martuza, et al.
Publicado: (2018)

Plasmatic exosome-derived circRNAs panel act as fingerprint for glioblastoma
por: Xia, Dongyan, et al.
Publicado: (2021)

Picric Acid as a Test for Albumen and Sugar in the Urine
por: Johnson, George
Publicado: (1883)

Validation of a urine color scale for assessment of urine osmolality in healthy children
por: Kavouras, Stavros A., et al.
Publicado: (2015)

Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning
por: Wang, Yuye, et al.
Publicado: (2023)

Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019)

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
por: Abrahamsson, Per-Anders
Publicado: (2017)

Purple urine bag syndrome (PUBS)
por: Liolios, Athanasios C., et al.
Publicado: (2008)

Protein microarray-mediated detection of antienterovirus antibodies in serum
por: Zhang, Aiying, et al.
Publicado: (2016)

Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: He, Lei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vo5tlup8o2321uscn2jqbjsbhg